Business Context and Reporting Period
Company: AmerisourceBergen Corporation (Note: The company later rebranded to Cencora, Inc.)
Filing Date: February 17, 2021
Reporting Period: Current Report (Form 8-K) regarding events occurring on February 17, 2021.
Context: The filing details the entry into material definitive agreements to secure financing for the proposed acquisition of the majority of Walgreens Boots Alliance, Inc.'s (WBA) Alliance Healthcare businesses.
Key Financial Metrics and Debt Structure
This filing focuses on debt financing arrangements rather than operating performance metrics such as revenue or profit. Key financial terms include:
- Term Loan Facility: A senior unsecured term facility of $1.0 billion. Proceeds are designated to pay a portion of the cash consideration for the WBA transaction and related fees.
- Revolving Credit Facility: A senior unsecured revolving credit facility of $1.0 billion. Borrowings become available upon the consummation of the transaction.
- Bridge Financing Adjustment: Existing bridge financing commitments of $3.025 billion were automatically reduced by the amount of the new Term Credit Agreement commitments.
- Interest Rates (Term Loan): LIBO rate plus 87.5 to 137.5 basis points, or Base rate plus 0 to 37.5 basis points, based on credit ratings.
- Interest Rates (Revolving): LIBOR plus 83.5 to 125 basis points, or Base rate plus 0 to 25 basis points, based on credit ratings.
- Financial Covenants: A financial leverage ratio not to exceed 3.50 to 1.00 (increasable to 4.00 to 1.00 upon transaction closing).
Material Changes Versus Prior Period
The filing does not report changes in operating results compared to a prior period. The material change is the establishment of new debt facilities:
- Execution of a $1.0 billion Term Credit Agreement.
- Execution of a $1.0 billion 364-Day Revolving Credit Facility.
- Reduction of previously disclosed $3.025 billion in bridge financing commitments.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The financing is contingent on the consummation of the transaction with WBA. The Term Loan matures two years from the draw date, while the Revolving Facility matures 364 days after the transaction closing (with an option to extend).
Risks and Contingencies:
- Transaction Dependency: Funding under the Term Credit Agreement and availability of the Revolving Facility are subject to the closing of the WBA transaction.
- Covenants: The agreements include limitations on indebtedness, liens, fundamental changes, and asset sales. Failure to comply with the financial leverage ratio or other covenants could trigger events of default.
- Related Party Transactions: Lenders and their affiliates (including JPMorgan, BofA, and Wells Fargo) have existing relationships with the company, including roles in past securities offerings and a $1.45 billion receivables securitization facility.
Key Facts for Investor Verification
- Verify the status of the proposed acquisition of WBA's Alliance Healthcare businesses, as the new debt facilities are contingent on this closing.
- Confirm the company's current credit ratings from Standard & Poor's and Moody's, as these directly determine the interest rate margins on the new facilities.
- Monitor the company's compliance with the 3.50 to 1.00 financial leverage ratio covenant.
- Review the reduction of the $3.025 billion bridge financing to understand the total capital structure for the transaction.